Apostolidou K

No ORCID on file · 1 paper in corpus · active 2022
2022
Frontiers in oncology ·doi:10.3389/fonc.2022.1030786

BackgroundGermline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond these mutations, germline or somatic aberrations in genes of the homologo…